Present developments in reaching an international consensus for a model-based approach to particle beam therapy

Area of Science:

• Oncology
• Medical Physics
• Radiotherapy Research

Background:

• Particle beam therapy (PBT), encompassing proton and carbon ion therapy, represents an advanced cancer treatment modality.
• High treatment costs and limited accessibility necessitate precise patient selection to maximize PBT benefits over standard X-ray therapy (XRT).
• Model-based approaches (MBA) are increasingly vital for generating evidence due to the resource intensity of randomized controlled trials.

Purpose of the Study:

• To address the need for PBT-specific predictive models by highlighting limitations of existing models derived from XRT data.
• To emphasize the necessity of prospective toxicity analysis for developing PBT-compatible normal tissue complication probability (NTCP) models.
• To outline a systematic, multi-step approach for developing and validating robust PBT predictive models.

Main Methods:

• Reviewing the principles and applications of the model-based approach (MBA) in radiotherapy.
• Identifying critical steps for developing reliable PBT predictive models, including patient selection, treatment planning, and data analysis.
• Discussing the integration of advanced technologies in radiotherapy and computer science for enhanced treatment efficacy.

Main Results:

• Existing normal tissue complication probability (NTCP) models are often based on historical XRT data, limiting their direct applicability to PBT.
• An international consensus underscores the requirement for systematically developed models to ensure accuracy and performance in PBT.
• Six key steps are identified: patient selection, treatment planning, beam delivery, dose verification, response assessment, and data analysis.

Conclusions:

• Developing PBT-compatible predictive models, particularly NTCP models, requires prospective analysis of treatment-specific toxicities.
• A systematic, evidence-based approach integrating advanced technologies is essential for accurate PBT patient selection and treatment optimization.
• Model validation, cost-effectiveness analysis, and quality assurance are critical prerequisites for the clinical implementation of PBT.